Member Info for Livedataaccount

I would just like to put it out there that shaun Chilton and our Christina won't have the emotional attachment to Avacta Alan had. Things are likely to move faster now. They won't be trying to build Avacta into Glaxosmithkline

Let's get 1b started!

30million gbp

Of for crying out loud ice

Much like there is no phase 1b

I use the same calendar as the previous CEO

End of arm 2 was supposed to end mid year?

Mid year was technically June 15th midday

Maybe she knows something we don't?

Unless a deal is done before the next loan repayment.

I want it to be paid in shares.

Reckless to use cash pile when it will run out next year. And will weaken any negotiations

The way you need to look at it is. Avacta are halfway through phase 1. Yes it's taken years to get this far and the previous CEO was a master of dangling carrots to investors. Phase 1b is scheduled to start in the second half of this year. Phase 2 next year. It's actually still elvery early days in the trial.

Il

I wish I was paid to post.

I'm a long term suffering investor looking at options avacta could turn this around.

I've seen nothing from affimersto boost the share price long term or dx.

Precision is the future for me. Get well into phase 2 and sell the company.

Don't all have to agree.

What diagnostics screenings though? .

Are avacta after 17 years going start selling these en masse?

I can't see it.

Becoming a pure pre cision play I say.

Keep it clean and simple amd do that well.

Then flog the company

Affimer weren't always about that LFT though. That was avacta seeing an opportunity during the pandemic for lfts

I mean more generally

Avacta have been in existence for around 17 years

It seems the chance for the company to really be expand the market cap is pre cision.

I would vote to sack off dx and affimers

And set a clear timeline on the next product for the clinic. And do it soon

I don't know enough, but seems to me like the dx it dilutes the avacta brand. Big pharma may think it's all too messy and fragmented. Seems to me pre cision is all that matters. Market that 100%

Thisnis avacta and this is what we do.

Surely easier to sell the company that way or attract partners and big investors. Rather than the Leeds University spin off

I don't get the whole affimer thing.

Have Avacta ever done anything with affimer? Is it even close to being monitised?

I don't get the whole affim

Is the size of this short position now bigger than Alan's strategic European healthcare investor?

No ice, it was always phase 1b.

As you were told many times oversame goes for Bella

The truth.

They have. And at least they are now calling it phase 1b. That will start in 2h 2024